1. Home
  2. POWWP vs REVBW Comparison

POWWP vs REVBW Comparison

Compare POWWP & REVBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWWP
  • REVBW
  • Stock Information
  • Founded
  • POWWP N/A
  • REVBW N/A
  • Country
  • POWWP United States
  • REVBW United States
  • Employees
  • POWWP 342
  • REVBW 9
  • Industry
  • POWWP Ordnance And Accessories
  • REVBW Biotechnology: Pharmaceutical Preparations
  • Sector
  • POWWP Industrials
  • REVBW Health Care
  • Exchange
  • POWWP Nasdaq
  • REVBW Nasdaq
  • Market Cap
  • POWWP N/A
  • REVBW N/A
  • IPO Year
  • POWWP N/A
  • REVBW 2020
  • Fundamental
  • Price
  • POWWP $22.05
  • REVBW $0.02
  • Analyst Decision
  • POWWP
  • REVBW
  • Analyst Count
  • POWWP 0
  • REVBW 0
  • Target Price
  • POWWP N/A
  • REVBW N/A
  • AVG Volume (30 Days)
  • POWWP N/A
  • REVBW N/A
  • Earning Date
  • POWWP N/A
  • REVBW N/A
  • Dividend Yield
  • POWWP N/A
  • REVBW N/A
  • EPS Growth
  • POWWP N/A
  • REVBW N/A
  • EPS
  • POWWP N/A
  • REVBW N/A
  • Revenue
  • POWWP N/A
  • REVBW N/A
  • Revenue This Year
  • POWWP N/A
  • REVBW N/A
  • Revenue Next Year
  • POWWP N/A
  • REVBW N/A
  • P/E Ratio
  • POWWP N/A
  • REVBW N/A
  • Revenue Growth
  • POWWP N/A
  • REVBW N/A
  • 52 Week Low
  • POWWP N/A
  • REVBW N/A
  • 52 Week High
  • POWWP N/A
  • REVBW N/A
  • Technical
  • Relative Strength Index (RSI)
  • POWWP 59.02
  • REVBW N/A
  • Support Level
  • POWWP $21.00
  • REVBW N/A
  • Resistance Level
  • POWWP $22.79
  • REVBW N/A
  • Average True Range (ATR)
  • POWWP 1.06
  • REVBW 0.00
  • MACD
  • POWWP 0.14
  • REVBW 0.00
  • Stochastic Oscillator
  • POWWP 78.91
  • REVBW 0.00

About POWWP AMMO Inc. 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock

AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.

About REVBW Revelation Biosciences Inc. Warrant

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of therapies for the prevention and treatment of disease using trained immunity. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: